Metraipolis › archive › dc_f0065a3cbddf

Efficacy and safety of the CAPTEM regimen in patients with advanced adrenocortical carcinoma — Europe PMC PMID:42775983

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42775983
DOI
10.1530/ec-26-0136
License (as archived)
solo-consultazione
Archived
2026-11-01T07:59:01.503Z
SHA-256 of the archived text
08c989d40d416a5c238272e0e12785030d36a3b5715461a33abac175db9e770b
Stable URL of this page
https://metraipolis.com/documento/dc_f0065a3cbddf

How to cite

Efficacy and safety of the CAPTEM regimen in patients with advanced adrenocortical carcinoma — Europe PMC PMID:42775983 — Europe PMC (en), https://europepmc.org/article/MED/42775983 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f0065a3cbddf (Metraipolis archive dc_f0065a3cbddf, sha256 08c989d40d416a5c238272e0e12785030d36a3b5715461a33abac175db9e770b)
BibTeX
@misc{dcf0065a3cbddf,
  title = {Efficacy and safety of the CAPTEM regimen in patients with advanced adrenocortical carcinoma — Europe PMC PMID:42775983},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42775983},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f0065a3cbddf; sha256 08c989d40d416a5c238272e0e12785030d36a3b5715461a33abac175db9e770b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42775983. Agents can read the archived copy with the MCP tool read_document.